home / stock / rvnc / rvnc short
Short Information | Revance Therapeutics Inc. (NASDAQ:RVNC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 5,934,676 |
Total Actual Volume | 33,813,281 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 296,734 |
Average Short Percentage | 20.44% |
Is there a RVNC Short Squeeze or Breakout about to happen?
See the RVNC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $2.59 | $2.42 | $2.59 | $2.395 | 1,182,930 | 314,219 | 26.56% |
07-01-2024 | $2.57 | $2.57 | $2.75 | $2.53 | 1,762,280 | 380,644 | 21.6% |
06-28-2024 | $2.58 | $2.57 | $2.64 | $2.47 | 6,732,956 | 353,390 | 5.25% |
06-27-2024 | $2.36 | $2.58 | $2.58 | $2.31 | 1,835,431 | 409,767 | 22.33% |
06-26-2024 | $2.35 | $2.34 | $2.41 | $2.3 | 1,264,479 | 303,705 | 24.02% |
06-25-2024 | $2.57 | $2.35 | $2.59 | $2.34 | 1,677,065 | 463,108 | 27.61% |
06-24-2024 | $2.7 | $2.57 | $2.7799 | $2.56 | 1,217,732 | 256,813 | 21.09% |
06-21-2024 | $2.89 | $2.66 | $3 | $2.65 | 2,718,564 | 330,566 | 12.16% |
06-20-2024 | $2.81 | $2.87 | $2.88 | $2.745 | 828,936 | 166,569 | 20.09% |
06-18-2024 | $2.78 | $2.8 | $2.9 | $2.735 | 1,429,097 | 279,787 | 19.58% |
06-17-2024 | $2.8 | $2.8 | $2.86 | $2.74 | 1,458,811 | 306,105 | 20.98% |
06-14-2024 | $2.95 | $2.82 | $3 | $2.77 | 1,218,940 | 276,198 | 22.66% |
06-13-2024 | $3.02 | $2.97 | $3.145 | $2.96 | 781,791 | 171,884 | 21.99% |
06-12-2024 | $3.1 | $3.025 | $3.21 | $3 | 1,562,386 | 219,812 | 14.07% |
06-11-2024 | $2.73 | $2.94 | $2.96 | $2.72 | 1,625,506 | 190,441 | 11.72% |
06-10-2024 | $2.66 | $2.74 | $2.76 | $2.57 | 1,228,562 | 253,820 | 20.66% |
06-07-2024 | $2.86 | $2.7 | $2.915 | $2.68 | 1,280,004 | 314,846 | 24.6% |
06-06-2024 | $3.03 | $2.9 | $3.04 | $2.88 | 1,028,766 | 253,975 | 24.69% |
06-05-2024 | $2.93 | $3.03 | $3.135 | $2.8811 | 1,597,428 | 277,538 | 17.37% |
06-04-2024 | $3.01 | $2.91 | $3.02 | $2.8 | 1,381,617 | 411,489 | 29.78% |
News, Short Squeeze, Breakout and More Instantly...
Revance Therapeutics Inc. Company Name:
RVNC Stock Symbol:
NASDAQ Market:
Revance Therapeutics Inc. Website:
- Total net product revenue (DAXXIFY® and RHA® Collection) of $51.7 million, a YoY increase of 13%. - DAXXIFY® net revenue of $22.1 million, after a reduction of $2.0 million related to a consumer coupon program. - Toxin market share increased from 3.0% in Q4’23 to 3...
Conference Call Scheduled for Thursday, May 9, 2024 at 4:30 p.m. ET. Revance Therapeutics, Inc. (NASDAQ: RVNC), today announced that the company will release first quarter 2024 financial results on Thursday, May 9, 2024, after the close of market. Revance will host a corresponding confe...
– Two presentations highlighting data on DAXXIFY® for the treatment of cervical dystonia, including a new analysis from ASPEN trials assessing patient-desired retreatment intervals and one abstract examining the influence of DAXXIFY’s formulation on clinical performance ...